The antiviral activity of iota-, kappa-, and lambda-carrageenan against COVID-19: A critical review
Andri Frediansyah
Clinical Epidemiology and Global Health
Abstract
Though the carrageenan exhibited potent antiviral activity against SARS-CoV-2 and was used to treat COVID-19 under emergency protocol in conjunction with oral medications such as ivermectin, there is no solid evidence from clinical trials to support its efficacy. Thus, clinical trials are required to assess its efficacy for COVID-19 treatment prior to broad application.
Concepts
VirusHerpes simplex virusVirologyCoronavirusRabies virusSindbis virusBiologyRhinovirus